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Schizophrenia copy number variants and associative learning
NE Clifton1, AJ Pocklington1,2, B Scholz1, E Rees2, JTR Walters2, G Kirov2, MC O’Donovan1,2, MJ Owen1,2, LS Wilkinson1,2,3,
KL Thomas1,4 and J Hall1,2
Large-scale genomic studies have made major progress in identifying genetic risk variants for schizophrenia. A key ﬁnding from
these studies is that there is an increased burden of genomic copy number variants (CNVs) in schizophrenia cases compared with
controls. The mechanism through which these CNVs confer risk for the symptoms of schizophrenia, however, remains unclear. One
possibility is that schizophrenia risk CNVs impact basic associative learning processes, abnormalities of which have long been
associated with the disorder. To investigate whether genes in schizophrenia CNVs impact on speciﬁc phases of associative learning
we combined human genetics with experimental gene expression studies in animals. In a sample of 11 917 schizophrenia cases and
16 416 controls, we investigated whether CNVs from patients with schizophrenia are enriched for genes expressed during the
consolidation, retrieval or extinction of associative memories. We show that CNVs from cases are enriched for genes expressed
during fear extinction in the hippocampus, but not genes expressed following consolidation or retrieval. These results suggest that
CNVs act to impair inhibitory learning in schizophrenia, potentially contributing to the development of core symptoms of the
disorder.
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INTRODUCTION
Schizophrenia is a highly heritable psychiatric disorder charac-
terised by psychotic, cognitive and negative symptoms.1 Since the
disorder was ﬁrst named by Bleuler in the early 20th century,
abnormal association formation has been considered to represent
a core underlying feature of the condition.2 However, the overall
relationship between genetic risk for schizophrenia and
alterations in association formation in speciﬁc tasks such as fear
learning has not been well established.
In recent years major progress has been made in identifying
genetic variants contributing to risk for schizophrenia, which
include multiple common alleles of small effect and a signiﬁcant
component of rarer but more penetrant variants.3,4 In particular,
genomic studies have revealed a signiﬁcant increased burden of
rare chromosomal copy number variants (CNVs), which involve the
deletion or duplication of thousands of bases of DNA, in
schizophrenia patients compared with controls.4–7 Pathway analysis
of genes affected by these CNVs has revealed an enrichment for
genes implicated in processes involved in synaptic plasticity,
including genes encoding components of the NMDA receptor
complex and post-synaptic density.8,9 A key function of these
synaptic proteins is to regulate the molecular processes underlying
associative learning and memory.10–12 These ﬁndings are thus
consistent with documented deﬁcits in associative learning in
patients with schizophrenia, which have been considered to
contribute to the development and persistence of cognitive and
psychotic symptoms.13–18 However, it is not currently clear which
learning processes are affected by schizophrenia CNVs.
The molecular basis of associative learning has been investigated
in detail in animal models, in particular, in relation to contextual fear
memory processing in the hippocampus.19 These studies have
demonstrated that distinct molecular changes accompany the
consolidation, retrieval and extinction of contextual fear
associations20,21 and that each of these stages of fear memory
processing is accompanied by de novo gene expression.22,23 Notably,
memory extinction is recognised to be an active form of inhibitory
learning that serves to form a new secondary, stimulus-no event
association that competes with the original memory for control over
behaviour.24 Abnormalities in extinction learning and related forms of
inhibitory learning have been reported in patients with schizophrenia
and may contribute to the development and persistence of psychotic
and cognitive symptoms in the condition.15,25,26 It is not known,
however, which components of associative learning are affected by
genes in schizophrenia-associated CNVs.
Here, we have applied an integrated approach combining human
genetics, bioinformatics and experimental studies in animals to
investigate the hypothesis that genes in schizophrenia-associated
CNVs impact on molecular pathways engaged during speciﬁc
phases of associative learning. Speciﬁcally, we investigated whether
CNVs in schizophrenia cases from three large cohorts are selectively
enriched for genes expressed during the consolidation, retrieval or
extinction of fear associations in the hippocampus. Identifying
which speciﬁc cognitive processes are impacted by schizophrenia
risk genes is an important step towards determining how genetic
risk can lead to the development of the complex symptoms seen in
schizophrenia and related disorders.
MATERIALS AND METHODS
CNV samples and quality control
CNV data were compiled from three European case-control data
sets: the International Schizophrenia Consortium (ISC; 3395 cases,
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3185 controls), the Molecular Genetics of Schizophrenia
(MGS; 2215 cases, 2556 controls) study and a UK study of
schizophrenic patients taking clozapine combined with the Cardiff
Cognition in Schizophrenia sample (CLOZUK; 6307 cases, 10 675
controls),5,27,28 together, giving a total of 11 917 case and 16 416
control subjects. These CNV data sets have been previously
validated and full genotyping, CNV calling and quality control
information can be found in the original publications.4,5,8,27,28
Approval by the local ethics committee was granted for the use of
these samples in genetic association studies. All CNVs from the
ISC, MGS and CLOZUK data sets were annotated with their
overlapping genes from corresponding genome Builds 35, 36 and
37, respectively. Analyses were performed on CNVs at least 100 kb
in size and covered by at least 15 probes, to optimise CNV calling
reliability. For comparison analyses, CNVs were compared
between melanoma patients and additional non-psychiatric
phenotypes. These CNVs were obtained from a separate study29
and underwent the same ﬁltering process (2416 melanoma cases
and 6335 additional controls).
Consolidation, retrieval and extinction of contextual fear
associations
Associative learning was assessed in a previously published set of
experiments using hippocampus-dependent contextual fear con-
ditioning in rats.19 Conditioning was characterised by robust
conditioned freezing (immobility) responses upon re-exposure to
the training environment indicating robust contextual fear
conditioning and recall of contextual fear memory.20,21 For a full
description of the conditioning procedures and tissue collection
see Barnes et al. (2012)20 and Scholz et al. (2016).21 In all
experiments adult male Lister Hooded rats were placed into a
context for 3 min during which they received a single delivery of a
single-scrambled foot shock (0.5 mA, 2 s). We have previously
shown that this context-shock pairing is sufﬁcient to produce
reliable contextual fear conditioning.30,31 Rats were then killed 2 h
after either consolidation, retrieval or extinction of the
fear association. For the consolidation group, animals were killed
direct from their home cages 2 h after conditioning. For the
retrieval condition, animals were re-exposed to the conditioned
context 48 h after conditioning for 2 min only, a manipulation we
have shown produces a fear response but is not sufﬁcient to
engage extinction.30 For the extinction condition, animals were
re-exposed to the conditioned context 48 h later for 10 min, a
manipulation that is sufﬁcient to develop robust behavioural
extinction of the original context-fear association.30 To generate a
control group for the conditioning procedure, balanced for overall
stimulus exposure, we utilised dorsal hippocampal brain-derived
neurotrophic factor (BDNF) antisense infusions to block contextual
fear conditioning.31 Control rats (n= 8) received bilateral micro-
infusions of 2 nmol µl− 1 BDNF antisense oligonucleotides (5′-TCT
TCCCCTTTTAATGGT-3′) into the dorsal hippocampus, sufﬁcient to
block fear conditioning, whereas rats in the consolidation group
(n= 8) received BDNF missense oligonucleotides (5′ -ATACTTTC
TGTTCTTGCC-3′) at 1 µl per hemisphere into the dorsal hippo-
campus (AP − 3.50, relative to bregma). Infusions were given
90 min before placement into the conditioning context. To
generate a control condition for the retrieval group balanced for
stimulus exposure, we similarly used antisense infusions pre-
viously shown to block processes that support the maintenance of
the contextual fear memory, but not conditioning.31 Speciﬁcally,
control rats (n= 8) received dorsal hippocampal microinfusions of
2 nmol µl− 1 Zif268 antisense oligonucleotides (5′- GGTAGTTGT
CCATGGTGG-3′), whereas the retrieval group (n= 8) received
infusions of Zif268 missense oligonucleotides (5′-GTGTTCGGTA
GGGTGTCA-3′). All infusions were 90 min before re-exposure to
the context. In the extinction paradigm, to generate a control
group matched for exposure, rats were initially trained to
distinguish two contexts before contextual fear conditioning in
one of the two contexts. After 48 h of conditioning, rats in the
extinction group (n= 6) were re-exposed for 10 min to the
conditioned context whereas control animals (n= 6) were
re-exposed to the non-conditioned context. To assess contextual
fear in the rats, freezing behaviour was quantiﬁed during all
context exposures, as reported previously.20,21 These behavioural
data conformed to the expected patterns of conditioning and
within session reductions of freezing responses to the condition-
ing context, indicative of extinction. Rats were killed by CO2
inhalation 2 h after conditioning (consolidation group) or 2 h after
context exposure (retrieval and extinction groups) for tissue
extraction. Experiments were conducted in accordance with the
United Kingdom 1986 Animals (Scientiﬁc Procedures) Act (Project
licenses PPL 30/2236 and PPL 30/2722).
Microarray of hippocampal CA1 region gene expression
A full description of the microarray procedure and results can be
found in the original studies20,21 and are accessible through GEO
Series accession number GSE66153. The dorsal CA1 region of the
hippocampus was dissected and snap frozen before microarray
analysis. Samples from individual rats were hybridised to separate
microarrays (Affymetrix Rat Genome Array 230.2, Affymetrix, Santa
Clara, CA, USA) as described previously.20,21 There was no ampli-
ﬁcation of cDNA before hybridisation. Raw intensity data from
each of the three Affymetrix data sets (consolidation, retrieval and
extinction) were normalised using RMA and MAS5.0 procedures.21
Gene ranking and gene set selection
Rat genes targeted by Affymetrix probe sets were identiﬁed from
the Affymetrix Rat Genome Array 230.2 resources. Probe sets that
do not target a unique gene were ﬁltered from the data sets. Rat
Entrez gene IDs were converted to human homologues using their
shared HomoloGene ID (accessed through the MGI Vertebrate
Homology table 3 March 2015). Genes that did not have a unique
human homologue were excluded from the data sets. For each
independent consolidation, retrieval and extinction microarray
data set, MAS5.0 and RMA moderate t-test P-values, representing
the signiﬁcance of differential expression (increased or decreased),
were combined using Fisher’s method. In cases where several
Affymetrix probe sets targeted the same gene, their combined
P-values were further combined using Simes P-value correction
procedure, giving one P-value per gene. For gene set selection,
genes were ranked by this P-value. In primary analyses, the top 5%
learning-related genes were taken as the gene set. For secondary
analyses, the top 1, 2, 5, 10, 15, 20 and 25% genes from each data
set were used. For permutation correction, the entire gene list was
permuted 2000 times, each time taking the top 1–25% genes as
randomised gene sets.
Logistic regression analysis
Enrichment analysis was performed by comparing the number of
consolidation-, retrieval- and extinction-related genes that overlap
with case or control CNVs.8 For each gene set, case-control status
was regressed against the number of overlapping genes and the
following covariates: CNV size, number of genes per CNV, chip
type and CNV study. All analyses were two-tailed. Primary analyses
were corrected for multiple testing using Bonferroni’s correction.
Secondary analyses were corrected by calculating the fraction of
randomly permuted gene sets of the same size that yielded a case
enrichment as or more signiﬁcant, to remove the effect of
background enrichment (Supplementary Figure 1). The relative
contribution of individual genes to a gene set’s enrichment in case
CNVs was determined by performing the same logistic regression
analysis upon each gene independently. Since this was a
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secondary, exploratory comparison of individual gene enrichment,
no P-value correction was performed.
RESULTS
Schizophrenia CNV gene set enrichment analyses
Consolidation, retrieval and extinction of contextual fear memory
each affected the expression of a distinct group of genes in the
hippocampal CA1 region, with little overlap across the learning
conditions20,21 (Supplementary Figure 2). We therefore investi-
gated whether the top 5% genes differentially regulated at any
one of these stages of associative learning (Supplementary Tables
1–3) are statistically overrepresented amongst genes hit by CNVs
from patients with schizophrenia when compared with CNVs from
controls. Using a logistic regression analysis,8 we found a
signiﬁcant enrichment of extinction-related genes in patient CNVs
(extinction P= 3.9 × 10− 4, Bonferroni corrected, Figure 1). No such
enrichment was seen for consolidation- or retrieval-related genes
(consolidation P= 0.31; retrieval P= 0.23; Figure 1). Secondary
analyses conﬁrmed that the association of extinction-related
genes with schizophrenia CNVs was robust to variation in the
threshold used to deﬁne the gene sets (Figure 1). We further
conﬁrmed that the enrichment of the top 1% extinction-related
genes in schizophrenia case CNVs was present independently in
each of the three individual cohorts used in the analysis (ISC
P= 0.041, MGS P= 0.029 and CLOZUK P= 6.7 × 10− 4), indicating
that this enrichment is a general property of schizophrenia CNVs
and is not driven by one population or cohort (Supplementary
Table 4). The top 5% extinction-related genes were independently
enriched in CNVs from the CLOZUK study (P= 3.0 × 10−4), but not
in CNVs from MGS (P= 0.18) or ISC (P= 0.11), which reﬂects the
lower power of analyses in individual, smaller cohorts.
These results indicate that people with schizophrenia are
enriched for CNVs affecting genes involved in extinction learning.
To further investigate the origin of this effect, we examined the
enrichment of learning-related genes in deletion CNVs and
duplication CNVs separately. This analysis revealed that the top
5% extinction-related genes were enriched in both deletions
(P= 0.0034, Bonferroni corrected) and duplications (P= 0.042,
Bonferroni corrected; Figure 1), whereas the top 5% consolidation-
and retrieval-related genes were not enriched in either CNV type.
Control CNV enrichment analysis
To test whether the enrichment of extinction-related genes is
speciﬁc to schizophrenia-associated CNVs, we conducted a control
analysis using CNVs from an independent sample of 2416 patients
with melanoma vs 6335 control subjects. No association was
identiﬁed between consolidation-, retrieval- or extinction-related
genes and melanoma case CNVs (consolidation P= 0.59; retrieval
P= 1.0; extinction P= 1.0; Supplementary Table 5), conﬁrming that
the enrichment of extinction-related genes in schizophrenia CNVs
Figure 1. Extinction-related genes are enriched in copy number variants (CNVs) from patients with schizophrenia. (a) The top 5% genes
differentially expressed following fear extinction (Supplementary Table 3), but not consolidation (Consol) or retrieval, are overrepresented in
schizophrenia CNVs vs control CNVs (P= 3.9 × 10− 4). Bars represent − log10(P-value) after logistic regression enrichment analysis and
Bonferroni P-value correction. (b) Deletions from schizophrenic patients alone show an overrepresentation of fear extinction-related genes
(P= 0.0034, Bonferroni corrected). (c) The enrichment of fear extinction-related genes in duplications from schizophrenic patients is signiﬁcant
(P= 0.042, Bonferroni corrected) yet weaker than in deletions. (d–f) Enrichment analyses performed over the top 1, 2, 5, 10, 15, 20 and 25%
genes associated with consolidation, retrieval and extinction of fear memory. Points represent − log10(P-value) × sgn(Z-value) where P is
empirically determined from permutation correction (Supplementary Figure 1). For (a–f), dotted lines represent a P = 0.05 threshold for
statistical signiﬁcance.
Schizophrenia copy number variants and associative learning
NE Clifton et al
180
Molecular Psychiatry (2017), 178 – 182
is a selective effect and is unlikely to reﬂect a general property of
disease-associated CNVs.
Genetic overlap between extinction learning and schizophrenia
risk-loci
We ﬁnally sought to investigate which speciﬁc CNV-associated
genes drive the enrichment for genes differentially regulated
during extinction learning. The full gene set is listed in
Supplementary Table 3. We note that a number of the genes
driving the association with extinction learning reside within
recurrent CNVs implicated in schizophrenia including CLDN5, MFI2,
ATP10A, SNRPN and CGNL1 (Supplementary Table 6).4,28 We also
identiﬁed a number of overlapping genes whose biological
function remains to be well characterised, illustrating that our
combined bioinformatics and functional analysis can identify the
contribution to risk of genes that are not annotated sufﬁciently for
traditional pathway analysis approaches.
DISCUSSION
Our results demonstrate a selective impact of genes in
schizophrenia-associated CNVs on the molecular pathways
regulated by extinction learning. By using gene expression data
sets generated from functional experiments in animals we extend
previous results from pathway analyses of schizophrenia-
associated CNVs8,9 and studies of individual risk genes and familial
risk,32–34 and provide evidence that CNVs confer vulnerability to
the disorder by impacting on speciﬁc cognitive processes.
Our results are consistent with previous studies suggesting that
impaired extinction and inhibitory learning contribute to the
development of psychotic symptoms in schizophrenia.14,26,35
Indeed, an impairment in extinction learning could explain core
symptoms of the disorder, such as the characteristic persistence of
delusional beliefs in schizophrenia in the face of conﬂicting
evidence.15 Our ﬁndings are also consistent with previous work
showing impaired extinction of fear associations in schizophrenia
as well as persistent activation of the hippocampus to fearful
stimuli in the disorder.26,36,37 The observation that genes in
schizophrenia-associated CNVs are enriched for targets engaged
during extinction learning in the CA1 region of the hippocampus
also suggests a potential mechanistic explanation for the
heightened activation of the CA1 region seen in both prodromal
cases and individuals with established schizophrenia.36,38,39
Extinction and inhibitory learning are implicated in a number of
other psychiatric and neurodevelopmental disorders. Is it notable
that CNVs conferring risk to schizophrenia also confer risk for
other neurodevelopmental disorders,7,40 raising the possibility
that the link between CNVs and associative learning is of wider
relevance to those psychiatric disorders in which CNVs have a role.
We also note that although we show strong evidence of an
association of schizophrenia-related CNVs with extinction learning,
the experimental design makes it more difﬁcult to conclusively
reject any association with consolidation and retrieval phases of
associative learning.
The present results highlight the potential of using bioinfor-
matics to integrate human genetic studies with experimental
studies in model organisms in order to investigate the functional
processes impacted by genetic variation. This approach over-
comes some of the limitations of traditional pathway analyses,
which are constrained by the prior annotation of genes and gene
variants to functional pathways. The method used here, in
contrast, allows all genes to be included in the analysis, regardless
of their degree of prior functional annotation. The integration of
human genetic data with experiments in animal models is also
highly complementary to human post mortem gene expression
studies, allowing additional hypothesis testing about the func-
tional effects of risk-associated genetic variation.
Overall, these ﬁndings are consistent with the hypothesis that
altered associative learning contributes to the pathogenesis of
schizophrenia. Furthermore, they suggest that schizophrenia-
associated CNVs particularly impact on inhibitory forms of learning
such as extinction. Deﬁcits in extinction learning may contribute
to the development of both the cognitive and psychotic
symptoms seen in the condition. The present results also highlight
a novel approach to investigate the functional processes impacted
by complex genetic risk factors in neuropsychiatric disorders by
using bioinformatics approaches to integrate functional studies in
animals with human genetic data.
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